Back to search

Article

Longitudinal Vaccine-Induced Humoral Immune Response in Cancer Patients

2021-10-01

Abstract excerpt

Background: Longitudinal studies of mRNA vaccine-induced response demonstrate robust protection up to six months in healthy patients; however, evaluation of sustained response in cancer patients are lacking.<br><br>Methods: In a prospective cohort study, 366 (291 vaccinated) patients [171 (145) solid tumors, 195 (146) hematologic malignancies] were enrolled and followed from November 2020 through September 2021....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b3e7f82a-9e8a-5378-8555-38f731dca031
DOI
10.2139/ssrn.3934241
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Longitudinal Vaccine-Induced Humoral Immune Response in Cancer PatientsDOI 10.2139/ssrn.3934241
Immunogenicity of SARS-CoV-2 mRNA Vaccines in Patients with Cancer: Findings from an International Collaborative Cohort StudySemantic proximity
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE studySemantic proximity
Immune responses following third COVID-19 vaccination are reduced in patients with hematologic malignancies compared to patients with solid cancerSemantic proximity
Immunogenicity of SARS-CoV-2 mRNA Vaccines in Patients with Cancer: Findings from an International Collaborative Cohort StudySemantic proximity
Humoral and Cellular Immunity to SARS-CoV-2 Vaccination in Cancer Patients: Completed Prospective Observational Study Using BNT162b2 mRNA VaccineSemantic proximity
Infection by SARS-CoV-2 with alternate frequencies of mRNA vaccine boosting for patients undergoing antineoplastic treatment for cancerSemantic proximity
Aberrant B cell differentiation with reduced hypermutation limits humoral response maintenance and breadth in cancer patientsSemantic proximity
Cancer Therapy and Immunogenicity of COVID Vaccine – CANINE StudySemantic proximity
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.SSemantic proximity
Sustained Humoral Activation through self-amplifying mRNA Vaccination Enhances Longitudinal Antibody Function in a Phase III TrialSemantic proximity
Immunogenicity and Omicron Neutralization Following a Third COVID-19 Vaccination in Solid Cancer Patients Previously Primed with Two Doses of Chadox1 Vaccine: A Prospective Cohort StudySemantic proximity
Low dose mRNA-1273 COVID-19 vaccine generates durable T cell memory and antibodies enhanced by pre-existing crossreactive T cell memorySemantic proximity
Select a neighboring publication to make it the new centre.